Ignite Creation Date:
2025-12-24 @ 7:09 PM
Ignite Modification Date:
2026-03-01 @ 6:01 AM
Study NCT ID:
NCT06041503
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-12-24
First Post:
2023-09-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)
Sponsor:
Organization: